Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
196 ARTÍCULOS , VIENDO DEL 61 AL 75
Imaging biomarkers in neurodegeneration: current and future practices
Young PNE, Estarellas M, Coomans E, Srikrishna M, Beaumont H, Maass A, Venkataraman AV, Lissaman R, Jiménez D, Betts MJ, McGlinchey E, Berron D, O'Connor A, Fox NC, Pereira JB, Jagust W, Carter SF, Paterson RW, Schöll M.
Alzheimers Res Ther. 2020 Apr 27;12(1):49. doi: 10.1186/s13195-020-00612-7.
Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease
Mejido DCP, Peny JA, Vieira MNN, Ferreira ST, De Felice FG.
Neuropharmacology. 2020 Jul;171:108115. doi: 10.1016/j.neuropharm.2020.108115. Epub 2020 Apr 25.
Liu W, Lin H, He X, Chen L, Dai Y, Jia W, Xue X, Tao J, Chen L.
Transl Psychiatry. 2020 Apr 29;10(1):125. doi: 10.1038/s41398-020-0801-2.
Current and Future of Alzheimer's Therapy with the Best Approach
Singh H, Chawla V, Bala R, Dureja H.
CNS Neurol Disord Drug Targets. 2020;19(9):691-697. doi: 10.2174/1871527319666200430000538.
Tryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer's disease?
Maitre M, Klein C, Patte-Mensah C, Mensah-Nyagan AG.
Prog Neurobiol. 2020 Jul;190:101800. doi: 10.1016/j.pneurobio.2020.101800. Epub 2020 Apr 29.
Qin T, Prins S, Groeneveld GJ, Van Westen G, de Vries HE, Wong YC, Bischoff LJM, de Lange ECM.
Int J Mol Sci. 2020 Apr 30;21(9):3158. doi: 10.3390/ijms21093158.
Beaudreau SA, Schneider L.
Am J Geriatr Psychiatry. 2020 Jul;28(7):745-747. doi: 10.1016/j.jagp.2020.04.007. Epub 2020 Apr 15.
Combination Drug Therapy for the Management of Alzheimer's Disease
Kabir MT, Uddin MS, Mamun AA, Jeandet P, Aleya L, Mansouri RA, Ashraf GM, Mathew B, Bin-Jumah MN, Abdel-Daim MM.
Int J Mol Sci. 2020 May 5;21(9):3272. doi: 10.3390/ijms21093272.
Clinical significance of fluid biomarkers in Alzheimer's Disease
Lewczuk P, Łukaszewicz-Zając M, Mroczko P, Kornhuber J.
Pharmacol Rep. 2020 Jun;72(3):528-542. doi: 10.1007/s43440-020-00107-0. Epub 2020 May 8.
Lim HJ, Park JE, Kim BC, Choi SM, Song MK, Cho SH, Seo HJ, Kim J, Song HC, Choi KY, Lee JJ, Kim HW, Ha JM, Song WK, Park SG, Lee JS, Lee KH.
J Alzheimers Dis. 2020;75(3):949-958. doi: 10.3233/JAD-191331.
Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer's Disease
Pyun JM, Kang MJ, Ryoo N, Suh J, Youn YC, Park YH, Kim S.
J Alzheimers Dis. 2020;75(3):685-696. doi: 10.3233/JAD-200104.
Relevance of biomarkers across different neurodegenerative diseases
Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, Jafarpour M, Young PNE, Jagust W, Carter SF, Lashley T, Grinberg LT, Pereira JB, Mattsson-Carlgren N, Ashton NJ, Hanrieder J, Zetterberg H, Schöll M, Paterson RW.
Alzheimers Res Ther. 2020 May 13;12(1):56. doi: 10.1186/s13195-020-00601-w.
The age-related microglial transformation in Alzheimer's disease pathogenesis
Yuan C, Aierken A, Xie Z, Li N, Zhao J, Qing H.
Neurobiol Aging. 2020 Aug;92:82-91. doi: 10.1016/j.neurobiolaging.2020.03.024. Epub 2020 Apr 15.
Oxidative Stress and Dementia in Alzheimer's Patients: Effects of Synbiotic Supplementation
Ton AMM, Campagnaro BP, Alves GA, Aires R, Côco LZ, Arpini CM, Guerra E Oliveira T, Campos-Toimil M, Meyrelles SS, Pereira TMC, Vasquez EC.
Oxid Med Cell Longev. 2020 Jan 13;2020:2638703. doi: 10.1155/2020/2638703. eCollection 2020.
What to make of equivocal amyloid imaging results
Burrell JR, Foxe D, Leyton C, Piguet O, Hodges JR.
Neurocase. 2020 Jun;26(3):137-146. doi: 10.1080/13554794.2020.1764056. Epub 2020 May 15.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.